IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials
IQVIA Laboratories, a leading global drug discovery and development laboratory services organization, announces the launch of Site Lab Navigator, an advanced suite of solutions that automates and streamlines lab workflows for clinical trial sponsors and investigator sites.
At the core of Site Lab Navigator is a new, innovative e-Requisition solution, which allows investigator sites to submit requisitions and manage lab specimens electronically, eliminating the need for manual, paper-based processes. This reduces administrative burden, minimizes errors, drives compliance and improves study execution for both sponsors and investigator sites.
IQVIA Laboratories' e-Requisition solution within the Site Lab Navigator suite of applications is a unique technology solution that offers capabilities unmatched by other requisitioning solutions available:
- Seamless portal integration: Easy access via IQVIA's One Home for Sites™ single sign-on.
- Real-time sample tracking: End-to-end shipping visibility using courier data.
- Guided kit replacement: Online kit order management to minimize waste.
- Real-time data validation: Improved accuracy and acceleration of reporting times.
- Guided data entry: Elimination of data recording errors resulting in significant reduction in visit queries and streamlined patient reporting and database locks.
- Online sample collection guidance: Simplified workflows, reducing site burden and ensuring compliance.
"Site Lab Navigator and its differentiated e-Requisition solution will significantly reduce administrative burden on sites and improve the quality and execution of clinical trials for our customers," said David Morris, chief operating officer at IQVIA Laboratories. "The early response has been extremely positive, with a number of sponsors already signed on including several top 10 pharmaceutical companies. By equipping investigator sites with cutting-edge tools, we are streamlining workflows, improving data integrity and ultimately accelerating the path to high-quality results."
With automation of workflows, real-time validation of data captured and an intuitive user experience, the new e-Requisition solution reinforces IQVIA Laboratories' dedication to delivering innovative, site-centric solutions that drive faster, more accurate and efficient trial outcomes.
For more information about Site Lab Navigator and e-Requisition, visit www.labs.iqvia.com/investigator-support.
About IQVIA Laboratories
IQVIA Laboratories is a leading global drug discovery and development laboratory services organization offering a comprehensive suite of central laboratory and specialty biomarker services. Our expertise spans central laboratory, genomics, immunoassays, flow cytometry, anatomic pathology, precision medicine, vaccine, ADME, and bioanalytical services. IQVIA Laboratories also brings extensive expertise in antibody drug discovery, biomarker discovery, and decentralized clinical trial laboratory solutions.
With a commitment to scientific excellence and operational efficiency, IQVIA Laboratories supports the entire drug development lifecycle across diverse regions and regulatory landscapes, ensuring data integrity and optimizing research to bring life-changing therapies to patients faster. To learn more visit www.labs.iqvia.com.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA's portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250304097031/en/
Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)
+1.973.541.3558
Alissa Maupin, IQVIA Media Relations (alissa.maupin1@iqvia.com)
+1.919.923.6785